It was another busy week for Australia's leading brokers, with several new research notes being released following company updates and results.
Three ASX shares that have been given buy ratings are listed below. Here's why brokers believe they could be worth considering:
According to a note out of Citi, its analysts have retained their buy rating and $40.80 price target on this appliances manufacturer's shares. The broker was pleased with the latest quarterly results from Breville's US retail distribution partner, Williams-Sonoma, which revealed stronger-than-expected sales. The Williams Sonoma brand reported comparable sales growth of 6.8%, comfortably ahead of consensus expectations of 5.1%. This was achieved despite reduced promotional activity, suggesting that demand for premium kitchen appliances remains resilient.
Citi also highlights that Williams-Sonoma management identified Breville's exclusive Auto Pour Over coffee machine as an important product for the upcoming holiday shopping period. Although the retailer didn't provide specific coffee category sales figures, the broker believes the update is encouraging for Breville's premiumisation strategy. With the company's international expansion continuing and demand for its premium products holding up, Citi remains positive on its outlook. The Breville share price ended the week at $31.01.
Analysts at Bell Potter have retained their buy rating on this family safety technology company's shares with an increased price target of $30.60. This follows the broker upgrading its revenue and adjusted EBITDA forecasts for 2027 and 2028 by approximately 2%. Bell Potter highlights that Life360 has recently increased the prices of its Silver and Gold memberships in the US by US$2 per month. The broker believes these increases will support higher average revenue per paying circle, although they could temporarily weigh on subscriber growth.
Looking ahead, Bell Potter is forecasting adjusted EBITDA growth of 46% in 2027, supported by revenue growth of 25% and an improvement in profit margins from 20.2% to 23.7%. These forecasts are towards the upper end of market expectations, highlighting the broker's confidence in Life360's outlook. Bell Potter also believes the March quarterly update and accompanying guidance could provide positive catalysts for its shares. The Life360 share price ended the week at $20.60.
A note out of Morgans reveals that its analysts have retained their buy rating on this agricultural chemicals and seed technology company's shares with a reduced price target of $4.14. The broker was pleased with Nufarm's FY 2026 results, which revealed a 25% increase in underlying EBITDA to $378.3 million. This was driven largely by the company's higher-value Seed Technologies business, while management's turnaround strategy helped improve margins, strengthen cash flow, and reduce debt.
Although Nufarm's guidance for approximately 8% EBITDA growth in FY 2027 was slightly below Morgans' expectations, the broker believes management is being conservative. This is because its guidance doesn't assume any improvement in market conditions or pricing. Morgans also expects further earnings growth in FY 2028 as the benefits of a second $50 million cost reduction programme are realised. With the turnaround progressing well and debt continuing to fall, the broker believes Nufarm shares are undervalued at current levels. The Nufarm share price ended the week at $2.87.
The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.
Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026